AL, G., RG, W., D, T., AC, S., MX, R., M, Q., . . . M, H. (2022). End-point definition and trial design to advance tuberculosis vaccine development. European respiratory review : an official journal of the European Respiratory Society, 31(164), . https://doi.org/10.1183/16000617.0044-2022
Chicago Style (17th ed.) CitationAL, Garcia-Basteiro, et al. "End-point Definition and Trial Design to Advance Tuberculosis Vaccine Development." European Respiratory Review : An Official Journal of the European Respiratory Society 31, no. 164 (2022). https://doi.org/10.1183/16000617.0044-2022.
MLA (9th ed.) CitationAL, Garcia-Basteiro, et al. "End-point Definition and Trial Design to Advance Tuberculosis Vaccine Development." European Respiratory Review : An Official Journal of the European Respiratory Society, vol. 31, no. 164, 2022, https://doi.org/10.1183/16000617.0044-2022.